Interleukin-21 Receptor Might be a Novel Therapeutic Target for the Treatment of Rheumatoid Arthritis
Conclusion Our results indicate higher expression of IL-21R in RA patients and suggest that targeting of the IL-21R may be a novel therapeutic idea for the treatment of RA.
Source: Journal of Experimental and Clinical Medicine - Category: Journals (General) Source Type: research
More News: Arthritis | Autoimmune Disease | General Medicine | Pathology | Rheumatoid Arthritis | Rheumatology | Study